financetom
Business
financetom
/
Business
/
Volkswagen looks forward to working with U.S. gov't amid tariff concerns, spokesperson says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Volkswagen looks forward to working with U.S. gov't amid tariff concerns, spokesperson says
Jan 21, 2025 12:56 AM

BERLIN, Jan 21 (Reuters) - Volkswagen is

looking forward to working with the new U.S. administration, the

German carmaker said on Tuesday, and stressed the importance of

dialogue amid concerns about the impact of tariffs proposed by

President Donald Trump.

"The Volkswagen Group is concerned about the harmful

economic impact that proposed tariffs by the U.S. administration

will have on American consumers and international automotive

industry," a Volkswagen spokesperson said in an emailed

statement to Reuters.

"We value collaboration and open dialogue. The Volkswagen

Group looks forward to continuing its longstanding and

constructive partnership with the U.S. administration," the

spokesperson added.

(Reporting by Christina Amann, Writing by Rachel More

Editing by Ludwig Burger

)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cytokinetics Insider Sold Shares Worth $405,420, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $405,420, According to a Recent SEC Filing
Oct 6, 2025
04:32 PM EDT, 10/06/2025 (MT Newswires) -- Edward M. Kaye, Director, on October 06, 2025, sold 6,757 shares in Cytokinetics ( CYTK ) for $405,420. Following the Form 4 filing with the SEC, Kaye has control over a total of 9,778 common shares of the company, with 9,778 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000106198325000008/xslF345X05/form4.xml ...
US court rejects Novo Nordisk's challenge to Medicare drug pricing plan
US court rejects Novo Nordisk's challenge to Medicare drug pricing plan
Oct 6, 2025
* Court upholds Medicare's drug price negotiation power * Novo Nordisk's constitutional challenges rejected by 3rd Circuit * Multiple drugmakers' lawsuits against Medicare program have failed in appellate courts By Diana Novak Jones CHICAGO, Oct 6 (Reuters) - A federal appeals court on Monday rejected Novo Nordisk's challenge to the U.S. government's program that gives its Medicare health insurance plan...
STAAR Shareholder Yunqi Capital Urges Rejection of Alcon Merger
STAAR Shareholder Yunqi Capital Urges Rejection of Alcon Merger
Oct 6, 2025
04:33 PM EDT, 10/06/2025 (MT Newswires) -- Yunqi Capital, a 5.1% shareholder in STAAR Surgical ( STAA ) , reaffirmed its opposition to the company's planned merger with Alcon (ALC), saying the $28-per-share deal undervalues STAAR and is opportunistic. The investor said recent sales declines in China were temporary and that STAAR's market position and implantable lens technology remain strong....
Turkish Airlines sees Pratt engine woes lasting to mid-2027
Turkish Airlines sees Pratt engine woes lasting to mid-2027
Oct 6, 2025
* Carrier has dozens of jets grounded by engine repair delays * Next year will continue in same fashion, Turkish CFO says * Engine bottlenecks overshadow ISTAT air finance conference By Tim Hepher PRAGUE, Oct 6 (Reuters) - Turkish Airlines (THY) expects bottlenecks in engine repairs that have grounded dozens of its Airbus jets for months at a time to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved